New rehabilitation protocols lead to restored neurological function in three paralyzed men who sustained cervical spinal cord injuries years ago.
An international team has utilized neuronal cells programmed from genetically identical pigs to eliminate the need for immunosuppression measures.
View webinar on demand.
Examining changes in cognition in clinical pharmacology studies, with an emphasis on the importance of starting early in clinical development.
A research team has identified a gene that, upon elimination, could potentially spur regeneration of axons in nerve cells severed by spinal cord injury.
For the first time, researchers have discovered that non-gene mutations could cause rare developmental disorders of the CNS.
A natural human monoclonal antibody protects from axonal injury in different CNS degenerative disease models
Discover the factors that inhibit axon regrowth following CNS injury and the potential therapeutics being developed to overome them, in this special report from Future Neurology.
Gamma Knife treatment of recurrent CNS metastases of pancreatic origin: a case report and review of the literature
In this case report from CNS Oncology the authors present a rare case of a patient with multiple recurrent brain metastases of pancreatic origin.
Assessing how drugs affect the CNS is becoming an increasing concern, particularly for road safety. In January 2015, the FDA issued the Draft Guidance – Evaluating Drug Effects on the Ability to Operate a Motor Vehicle. 2 years later, where are we now?
An evaluation of ‘IL4I1 augments CNS remyelination and axonal protection by modulating T-cell driven inflammation’, recently published in Brain.
Current update of adoptive immunotherapy using cytokine-induced killer cells to eliminate malignant gliomas
The article reviews current literature on the use of adoptive immunotherapy for malignant gliomas as well as the
the concept of antitumor activity mediated by CIK cells.